日用化学品科学2025，Vol.48Issue(1)：9-13,5.DOI:10.3969/j.issn.1006-7264.2025.01.002
底妆产品的体外和人体妆效评价方法研究
Research on the in vitro and clinical efficacy evaluation methods for foundation products
彭婷婷 1郭俊斌 1何丽娜 1谭勇 2郭沈涛3
作者信息
- 1. 广州润泽检测技术有限公司,广东 广州 510663
- 2. 山东花物堂生物科技有限公司,山东 济南 250101
- 3. 广州润泽检测技术有限公司,广东 广州 510663||山东花物堂生物科技有限公司,山东 济南 250101
- 折叠
摘要
Abstract
The study aimed to establish a combination of in vitro and clinical efficacy evaluation methods for foundation products.The coverage,whiteness,waterproof and sweat resistance effects were evaluated by in vitro tests,where CR ratio,Individual Type Angle(ITA°)and chromatic aberration(∆E)were measured as the evaluation indicators by standard black/white cardboard,artificial leather and artificial sweat.In the clinical assessment,the anti-stain,waterproof,sweat resistance effect of the foundation products were evaluated through the ∆E change,before and after the treatment of products by staining,wetting,and sweating on forearm skin.There were significant differences in CR ratio of different types of samples on the standard black and white cardboard(P<0.05).ITA° of artificial leather had a significant increase after treatment(P<0.05).The color difference ∆E value of black cloth after dipping test was greater than 1.5,and the color difference ∆E value of leather before and after treatment with water and artificial sweat was less than 1.5.Clinical assessment showed that ∆E＜50%,which had no significant difference in human skin color,before and after the test(P>0.05).The change trend of in vitro efficacy evaluation test was basically consistent with that of the visual evaluation and clinical assessment,indicated that the in vitro and clinical efficacy evaluation methods of foundation products are intuitive,quantifiable,and can be used to evaluate the efficacy of foundation products.关键词
底妆/遮盖力/物理美白/抗沾性/防水/抗汗Key words
foundation products/covering power/physical whitening/anti-stain/waterproof/sweat resistant分类
化学化工引用本文复制引用
彭婷婷,郭俊斌,何丽娜,谭勇,郭沈涛..底妆产品的体外和人体妆效评价方法研究[J].日用化学品科学,2025,48(1):9-13,5.
